Health & Life Sciences

Secure, governed data sharing for life sciences

For pharma, biotech, and health data organizations that need to share data externally — without losing control of it.

See how it works
Overview

Health and life sciences data is too valuable, and too sensitive, for standard sharing models.

Sensitive data. External partners. The stakes are too high for improvised infrastructure.
Sensitive, regulated, and commercially valuable data cannot be shared the way other data is shared. Standard file transfer and download-based delivery create unacceptable exposure.

Harbr provides two capabilities purpose-built for this environment: a Trusted Research Environment for secure in-place collaboration, and a governed data storefront to enable partners to discover, evaluate, and access data products. Both keep data under your control, while scaling with your partnerships and commercial ambitions.

The problem

Medical data demands more than standard sharing infrastructure can provide

The data that sits at the center of pharma R&D, clinical AI, and health analytics is some of the most sensitive and commercially significant in existence. The technologies used by organizations to share it externally were not built for this reality.

Too sensitive to share, too valuable not to

The data that sits at the center of pharma R&D, clinical AI, and health analytics is some of the most sensitive and commercially significant in existence. The technologies used by organizations to share it externally were not built for this reality.

Stalled collaboration

The data that sits at the center of pharma R&D, clinical AI, and health analytics is some of the most sensitive and commercially significant in existence. The technologies used by organizations to share it externally were not built for this reality.

Valuable data, poor distribution

The data that sits at the center of pharma R&D, clinical AI, and health analytics is some of the most sensitive and commercially significant in existence. The technologies used by organizations to share it externally were not built for this reality.

Governance gaps

The data that sits at the center of pharma R&D, clinical AI, and health analytics is some of the most sensitive and commercially significant in existence. The technologies used by organizations to share it externally were not built for this reality.

A better way

Built to share. Designed for control

Harbr isn't a document repository or a data portal. It's the layer that sits above your existing systems and data sources — standardizing how external access is packaged, published, governed, and delivered.

External audiences get a single, branded destination to discover what’s available, understand access terms, and request what they need — without going through multiple teams or submission forms.

Access is governed through subscription-based entitlements that reflect your policies, so each external party receives what they’re permitted —nothing more. Every access event is logged, traceable, and auditable without additional configuration.

The solution

Purpose-built for pharma, biotech, and health data organizations

Designed to work with your data ecosystem.Harbr works across your existing infrastructure and keeps data at source. It standardizes the layer above: how access is requested, approved, enforced, and audited — whether the use case is research collaboration, AI development, or commercial distribution.

Repeatable governance under scrutiny

Replace manual approvals and ad hoc provisioning with a consistent model designed to satisfy research ethics committees, ICO obligations, MHRA requirements, and commercial data agreements.

Precise access. Consistently enforced.

Access is governed through entitlements that reflect your policies and agreements. Entitlements are applied consistently across both research environments and data storefront delivery.

Policy made operational

Access is managed through entitlements that reflect your licensing terms, data sensitivity classifications, and permitted use cases. External parties are provisioned with exactly what they need, while conditions and restrictions are enforced by design.

Evidence that satisfies the most demanding reviewers

Granular logs of who accessed what, when, under which terms, and in which environment. Produced automatically across all external sharing without additional configuration – whether through the research environment or the data storefront.

Use cases

Two capabilities. One platform.

Built for the teams who own the value — and the risk

Harbr is for the teams who own external research collaboration and data distribution in health and life sciences — and for every compliance and governance stakeholder who needs to know it’s under control.

Unlock cross-organizational research — without the risk

Harbr gives pharma teams a governed, audit-ready hub for external research collaboration — where data stays at source, access is credentialed and controlled, and there’s no custom infrastructure to build.

Put medical data in front of the right buyers

Give buyers a place to find, evaluate, and access your datasets — securely and at scale.

Research data & informatics platforms

Responsible for enabling secure external collaboration on sensitive research data. Harbr removes the need to build bespoke environments project by project — providing a repeatable operating model that shortens time-to-collaboration.

Data governance and compliance

Responsible for ensuring external data access is lawful, auditable, and defensible. Harbr provides a single system of record for who accessed what, under which terms, and in which environment — supporting internal accountability and external regulations.

Data product & commercial teams

Accountable for distributing health data products to research teams, AI systems, and commercial customers. Harbr provides the storefront infrastructure and entitlement model to scale external access without rebuilding delivery workflows per customer.

Harbr: Governed infrastructure for external research collaboration

Get started